Development of a yeast retrotransposon-based system useful for screening of potentially active anti-retroviral compounds.

M. Sanguinetti, B. Posteraro, G. M. Rossolini, G. Satta

Research output: Contribution to journalArticlepeer-review

Abstract

We have developed a new system suitable for easy inexpensive screening of substances potentially active against HIV and other retroviruses. The system evaluates the ability of substances to inhibit the high-frequency induced retrotransposition of the yeast transposable element Ty917, and is based on an engineered version of the retrotransposon which carries a dominant selectable marker useful for scoring transposition events. The system performance was evaluated using two nucleoside analogues of proved anti-HIV activity, 3'-azido-3'deoxythymidine (AZT) and 2',3'-dideoxycytidine (ddC). Both substances were able to inhibit Ty917 transposition and could have been detected as potentially active antiretroviral drugs using the new screening system.

Original languageEnglish
Pages (from-to)117-125
Number of pages9
JournalNew Microbiologica
Volume18
Issue number2
Publication statusPublished - Apr 1995

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Development of a yeast retrotransposon-based system useful for screening of potentially active anti-retroviral compounds.'. Together they form a unique fingerprint.

Cite this